3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 51.50
-0.20 (-0.39%)
Apr 24, 2025, 1:46 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 3.99 billion as of April 24, 2025. Its market cap has increased by 102.36% in one year.
Market Cap
3.99B
Enterprise Value
3.37B
Revenue
265.69M
Ranking
n/a
PE Ratio
39.38
Stock Price
51.50
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 3.99B, an increase of 45.65%. That is a compound annual growth rate of 9.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 3.99B | -22.32% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | 2.64B | -3.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 160.86B |
| Caliway Biopharmaceuticals | 93.54B |
| Bora Pharmaceuticals Co., LTD. | 69.42B |
| Lotus Pharmaceutical | 56.52B |
| Polaris Group | 29.08B |
| Oneness Biotech | 27.68B |
| Pegavision | 25.55B |
| Lumosa Therapeutics | 25.50B |